SWAV — ShockWave Medical, Inc.

ShockWave Medical, Inc. (SWAV) 是一家 Medical - Devices 公司，屬於醫療保健產業, 目前交易價格為 $334.75. 其SharesGrow評分為 60/100, 表明高於平均的投資特徵， 7項中通過4項.

分析師共識目標價為 SWAV = $258 (-22.9% 上漲空間).

財務數據: 營收為 $730M, +135.1%/yr 平均成長. 淨利潤為 $147M, 成長率為 +839.5%/yr. 淨利潤率為 20.2% (強勁). 毛利率為 86.9% (+17.9 pp 趨勢).

資產負債表: 總債務為 $771M 對比 $669M 股東權益 (D/E比率 1.15, 適度). 流動比率為 11.76 (流動性強). 資產負債率為 49.2%. 總資產: $1.6B.

分析師展望: 4 / 13 位分析師評級 SWAV 為買入 (31%) — 意見分歧.

SharesGrow 7項標準細分: Value 12/100 (Fail), Growth 100/100 (Pass), Past 50/100 (Partial), Health 83/100 (Pass), Moat 76/100 (Pass), Future 16/100 (Fail), Income 85/100 (Pass).

$258.17

▼ 22.88% 下跌空間

Average Price Target

基於 13 位華爾街分析師對 ShockWave Medical, Inc. 提供的12個月價格目標，平均目標價為 $258.17，最高預測為 $360.00，最低預測為 $175.00。

Highest Price Target

$360.00

Average Price Target

$258.17

Lowest Price Target

$175.00

SWAV SharesGrow 評分概覽

60/100

SharesGrow Score

Above average fundamentals

View full scorecard →

價值 12/100

估值 — P/E, PEG, Forward PEG

成長 100/100

財務數據 — 平均成長

過去 50/100

強勁 — 趨勢

健康 83/100

資產負債表 — D/E比率, 流動比率為

護城河 76/100

毛利率為 + market cap

未來 16/100

分析師展望 — 為買入

收入 85/100

淨利潤率為

Scores derived from financial statements, analyst ratings, and balance sheet data.

評分明細 — SWAV

✗

價值 Fail

12/100

SWAV 本益比(P/E)為 N/A (S&P 500平均約25). 分析師共識目標價為 $258, 意味著 -22.9% 相對於當前價格 $335. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + 上漲空間 (25%) + trailing PEG (20%). ≥ 60 = Pass.

SWAV: +135.1%/yr 營收為, +839.5%/yr 淨利潤為平均成長. > 5%/yr — 強勁. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

SWAV: 2 / 4 年獲利. 較弱. Score = 2 / 4 × 100. ≥ 80 = Pass.

資產負債表 SWAV: D/E比率 1.15 (適度), 流動比率為 11.76 (流動性強). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

SWAV: 毛利率為 86.9% (+17.9 pp 趨勢), $13B market cap. Moat (0-100): margin (35%) + 趨勢 (15%) + market cap (30%) + 營收為 (20%). Score 76/100. ≥ 70 = Pass.

分析師展望: 4 / 13 位分析師評級 SWAV 為買入 (31%). 分析師共識目標價為 $258 (-22.9% 上漲空間). Score: 60% buy consensus + 40% 上漲空間. ≥ 60 = Pass.

SWAV: 淨利潤率為 20.2%. 健康 (≥15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

Stock Chart & Stats

市場數據

52週區間157.0-334.9

成交量3.95M

30日平均成交量1.25M

市值$12.57B

Beta（1年）0.88

Share Statistics

EPS（TTM）4.01

流通股數$36.71M

IPO Date2019-03-07

Employees1,468

CEODouglas E. Godshall

Financial Highlights & Ratios

Revenue (TTM)$730.23M

Gross Profit$634.84M

EBITDA$176.35M

Net Income$147.28M

Operating Income$165.99M

Total Cash$990.55M

Total Debt$770.61M

Net Debt$442.19M

Total Assets$1.57B

Price / Earnings (P/E)83.5

Price / Sales (P/S)17.21

Analyst Forecast

1Y Price Target$239.50

Target High$360.00

Target Low$175.00

上漲空間-28.5%

評級共識Hold

覆蓋分析師數13

買入 31% 持有 62% 賣出 8%

公司資訊

國家US

交易所NASDAQ Global Select

貨幣USD

ISINUS82489T1043

股價走勢

SWAV

ShockWave Medical, Inc. ↗ · NASDAQ Global Select

Healthcare • Medical - Devices

157.00 52WK RANGE 334.90

其他人也在看

Edwards Lifesciences Corporation

Align Technology, Inc.

ShockWave Medical, Inc. SWAV NASDAQ

SWAV SharesGrow 評分概覽

評分明細 — SWAV

Stock Chart & Stats

股價走勢

其他人也在看

獲取低估股票提醒